Literature DB >> 15194415

Short-term immunosuppression reduces fibrotic cellular infiltration around barium-M-alginate microbeads injected intraportally.

Z Mathe1, P Bucher, D Bosco, A Andres, C Fux, C Toso, J Oberholzer, C Wandrey, D Sainz-Vidal, D Espinosa, L Bühler, P Morel, T Berney.   

Abstract

INTRODUCTION: One of the major barriers affecting the viability of encapsulated islets is pericapsular fibrotic infiltration (PFI). This study aimed to design strategies to reduce PFI around intraportally injected alginate microbeads.
METHODS: Empty, highly purified, barium-M-alginate microbeads (400 microm) were injected intraportally into Lewis rats (3000 beads/rat). Rats (n = 9/group) were treated daily with either rapamycine (RAPA; 1 mg/kg/d p.o.), tacrolimus (TAC; 2 mg/kg/d p.o.), a combination of both, or gadolinium-chloride (GdC13, 20 mg/kg/d i.v., at day -1 and day +4). Treatment was discontinued at 10 days. Three rats/group were sacrificed at 3, 7, and 42 days after transplantation. Cellular composition of PFI was evaluated by immunohistochemistry. Severity of the reaction to the beads was determined by measuring the thickness of PFI on histology.
RESULTS: The main cellular components of PFI in the liver were macrophages and myofibroblasts. There was a significant (P <.05) reduction in the thickness of PFI in all treated groups, even 6 weeks after transplantation. Encapsulated rat islets showed excellent insulin response to glucose in vitro, with a stimulation index of 3.6 +/- 2.0.
CONCLUSION: Combination of highly purified alginate with short-term immunosuppression reduces fibrotic overgrowth around microbeads injected intraportally.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194415     DOI: 10.1016/j.transproceed.2004.04.021

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

1.  MR-guided portal vein delivery and monitoring of magnetocapsules: assessment of physiologic effects on the liver.

Authors:  Thomas W Link; David Woodrum; Wesley D Gilson; Li Pan; Di Qian; Dara L Kraitchman; Jeff W M Bulte; Aravind Arepally; Clifford R Weiss
Journal:  J Vasc Interv Radiol       Date:  2011-08-04       Impact factor: 3.464

Review 2.  Encapsulated Islet Transplantation: Where Do We Stand?

Authors:  Vijayaganapathy Vaithilingam; Sumeet Bal; Bernard E Tuch
Journal:  Rev Diabet Stud       Date:  2017-06-12

Review 3.  Transplantation of Encapsulated Pancreatic Islets as a Treatment for Patients with Type 1 Diabetes Mellitus.

Authors:  Meirigeng Qi
Journal:  Adv Med       Date:  2014-01-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.